| Theoretical Basis, Experimental Design, and Computerized Simulation of Synergism and Antagonism in Drug Combination Studies | 2006/09/01 | English | 3,712 |
| Anthracyclines: Molecular Advances and Pharmacologic Developments in Antitumor Activity and Cardiotoxicity | 2004/05/28 | English | 2,584 |
| Glutamate Receptor Ion Channels: Structure, Regulation, and Function | 2010/08/17 | English | 2,454 |
| Mechanisms of Antimicrobial Peptide Action and Resistance | 2003/03/01 | English | 2,148 |
| International Union of Pharmacology. XXVII. Classification of Cannabinoid Receptors | 2002/06/01 | | 1,874 |
| The Physiology, Signaling, and Pharmacology of Dopamine Receptors | 2011/02/08 | English | 1,756 |
| The Blood-Brain Barrier/Neurovascular Unit in Health and Disease | 2005/05/23 | English | 1,696 |
| The Endocannabinoid System as an Emerging Target of Pharmacotherapy | 2006/09/01 | English | 1,415 |
| Vascular Endothelial Growth Factor and Angiogenesis | 2004/12/01 | English | 1,284 |
| Cyclic Nucleotide Phosphodiesterases: Molecular Regulation to Clinical Use | 2006/09/01 | English | 1,253 |
| Classification, Functions, and Clinical Relevance of Extracellular Vesicles | 2012/06/21 | English | 1,214 |
| Cyclooxygenase Isozymes: The Biology of Prostaglandin Synthesis and Inhibition | 2004/08/18 | English | 1,159 |
| International Union of Basic and Clinical Pharmacology. LXXIX. Cannabinoid Receptors and Their Ligands: Beyond CB1and CB2 | 2010/11/15 | English | 1,114 |
| Computational Methods in Drug Discovery | 2013/12/31 | English | 1,083 |
| Metabolism and Disposition Kinetics of Nicotine | 2005/02/24 | English | 1,081 |
| Strategies to Address Low Drug Solubility in Discovery and Development | 2013/01/01 | English | 1,081 |
| The Therapeutic Potential of Poly(ADP-Ribose) Polymerase Inhibitors | 2002/09/01 | | 1,014 |
| International Union of Basic and Clinical Pharmacology. LXXXI. Nomenclature and Classification of Adenosine Receptors—An Update | 2011/02/08 | English | 992 |
| International Union of Pharmacology. XLVII. Nomenclature and Structure-Function Relationships of Voltage-Gated Sodium Channels | 2005/12/01 | English | 947 |
| Uptake Pathways and Subsequent Intracellular Trafficking in Nonviral Gene Delivery | 2006/02/28 | English | 940 |
| International Union of Pharmacology LVIII: Update on the P2Y G Protein-Coupled Nucleotide Receptors: From Molecular Mechanisms and Pathophysiology to Therapy | 2006/09/01 | English | 931 |
| Brain-Derived Neurotrophic Factor and Neuropsychiatric Disorders | 2012/03/08 | English | 920 |
| Psychedelics | 2016/02/03 | English | 859 |
| The Intrarenal Renin-Angiotensin System: From Physiology to the Pathobiology of Hypertension and Kidney Disease | 2007/09/01 | English | 852 |
| Pharmacological and Clinical Aspects of Heme Oxygenase | 2008/03/01 | English | 833 |
| International Union of Pharmacology. XLVIII. Nomenclature and Structure-Function Relationships of Voltage-Gated Calcium Channels | 2005/12/01 | English | 814 |
| Therapeutic Effects of Xanthine Oxidase Inhibitors: Renaissance Half a Century after the Discovery of Allopurinol | 2006/02/28 | English | 814 |
| Pituitary Adenylate Cyclase-Activating Polypeptide and Its Receptors: 20 Years after the Discovery | 2009/09/01 | English | 797 |
| The Pharmacology and Clinical Pharmacology of 3,4-Methylenedioxymethamphetamine (MDMA, “Ecstasy”) | 2003/07/17 | English | 768 |
| International Union of Pharmacology. LXX. Subtypes of γ-Aminobutyric AcidAReceptors: Classification on the Basis of Subunit Composition, Pharmacology, and Function. Update | 2008/09/01 | English | 750 |